Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.

Original languageEnglish (US)
JournalNew England Journal of Medicine
Volume357
Issue number15
DOIs
StatePublished - Oct 11 2007
Externally publishedYes

Fingerprint

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Transplantation
Drug Therapy
Survival
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. / Lindor, Keith.

In: New England Journal of Medicine, Vol. 357, No. 15, 11.10.2007.

Research output: Contribution to journalArticle

@article{bfa0628daeeb4b3e811649ac30010afc,
title = "Ursodeoxycholic acid for the treatment of primary biliary cirrhosis",
abstract = "A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.",
author = "Keith Lindor",
year = "2007",
month = "10",
day = "11",
doi = "10.1056/NEJMct074694",
language = "English (US)",
volume = "357",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "15",

}

TY - JOUR

T1 - Ursodeoxycholic acid for the treatment of primary biliary cirrhosis

AU - Lindor, Keith

PY - 2007/10/11

Y1 - 2007/10/11

N2 - A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.

AB - A 52-year-old woman receives a diagnosis of primary biliary cirrhosis. Treatment with ursodeoxycholic acid is recommended. Therapy with this drug appears to prolong transplantation-free survival, although the mechanism of benefit is unclear.

UR - http://www.scopus.com/inward/record.url?scp=35248893940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35248893940&partnerID=8YFLogxK

U2 - 10.1056/NEJMct074694

DO - 10.1056/NEJMct074694

M3 - Article

C2 - 17928600

AN - SCOPUS:35248893940

VL - 357

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 15

ER -